Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients reported suicidal or self-harming thoughts, two weeks after similar action by the European Union.
  • ᴇᴍᴘᴇʀᴏʀ 帝OPAEnglish
    1·
    2 years ago

    And so it begins. These are the pretty immediate effects, the big worry is what is going to be unearthed further down the line.